Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,961.00
+50.10 (2.62%)
Jul 31, 2026, 3:29 PM IST
Emcure Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, Emcure Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹1,963. The average 1-year stock price forecast is 0.10% higher than the current stock price, while the lowest is ₹1,640 (-16.37%) and the highest is ₹2,260 (+15.25%).
Price Target: ₹1,963 (+0.10%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 24, 2026.
Analyst Ratings
The average analyst rating for Emcure Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains ₹1,970 → ₹2,100 | Buy | Maintains | ₹1,970 → ₹2,100 | +7.09% | Jun 24, 2026 |
Financial Forecast
Revenue This Year
104.41B
from 92.04B
Increased by 13.45%
Revenue Next Year
117.36B
from 104.41B
Increased by 12.40%
EPS This Year
60.85
from 52.29
Increased by 16.36%
EPS Next Year
75.52
from 60.85
Increased by 24.11%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.